site stats

Cphe885b12201

WebEudraCT Number: 2024-003747-22: Sponsor's Protocol Code Number: CPHE885B12201: National Competent Authority: Greece - EOF: Clinical Trial Type: EEA CTA WebCIO-Studienregister: Klinische Studien im CIO. Klinische Studien spielen bei der Entwicklung und Verbesserung von neuen Therapien eine wichtige Rolle. Für viele Patienten ermöglicht die Teilnahme an einer Klinischen Studie auch den Zugang zu innovativen Medikamenten. Jedes Jahr werden im CIO Aachen Bonn Köln Düsseldorf …

Studienregister - Klinische Studien - Forschung - Uniklinik Köln

WebApr 4, 2024 · A Phase 2 Study of PHE885, B-cell Maturation Antigen (BCMA)- Directed CAR-T Cells in Adult Participants With Relapsed and Refractory Multiple Myeloma. … WebAug 8, 2024 · EudraCT Number: 2024-005029-26 Sponsor Protocol Number: KF7039-01 Start Date: 2024-08-08 Sponsor Name: Grünenthal GmbH Full Title: A randomized, double-blind, placebo-controlled, Phase III trial to evaluate the efficacy and safety of intra-articular injections of RTX-GRT7039 in adult subjects with pain associated with osteoart... rumc physicians https://greatmindfilms.com

NCT05172596 - Victorian Cancer Trials Link

WebDec 22, 2024 · CPHE885B12201 2024-003747-22 (EudraCT Number) Plan for Individual participant data (IPD) Plan to Share Individual Participant Data (IPD)? YES. IPD Plan … WebThe EU Clinical Trials Register currently displays 43388 clinical trials with a EudraCT protocol, of which 7179 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006). WebBei einem Multiplen Myelom, auch als Morbus Kahler bezeichnet, handelt es sich um eine bösartige Tumorerkrankung im Bereich der Knochen und des Knochenmarks. Es entsteht durch eine entartete Plasmazelle, die sich im Knochenmark vermehrt und davon ausgehend im blutbildenden System verteilt. Die Ursachen für eine Erkrankung konnten bisher nicht ... scary horror films 2020

Remove header and footer graphics All content is the …

Category:PHE885 CAR-T Therapy in Adult Participants With Relapsed and …

Tags:Cphe885b12201

Cphe885b12201

Studienregister - Klinische Studien - Forschung - Uniklinik Köln

WebEudraCT Number: 2024-003747-22: Sponsor's Protocol Code Number: CPHE885B12201: National Competent Authority: Germany - PEI: Clinical Trial Type: EEA CTA WebCPHE885B12201: 2024-003747-22: NCT05172596: Eine Phase-2-Studie mit PHE885, B-Zell-Reifungsantigen (BCMA)-gerichteten CAR-T-Zellen bei erwachsenen Teilnehmern mit rezidiviertem und refraktärem multiplem Myelom. Status: Aktiv. Studienziel / Fragestellung Primäres Prüfziel.

Cphe885b12201

Did you know?

WebProtocol Number: CPHE885B12201 Version: 1.0 Date: 07-Dec-2024 CS026-BP-A01/Version 29.0/Effective: 11-Oct-2024 (Ref. CS026-BP) Page 1 of 72 ICON … WebCPHE885B12201: 2024-003747-22: NCT05172596: Eine Phase-2-Studie mit PHE885, B-Zell-Reifungsantigen (BCMA)-gerichteten CAR-T-Zellen bei erwachsenen Teilnehmern …

WebCPHE885B12201 : Brief Title: PHE885 CAR-T Therapy in Adult Participants With Relapsed and Refractory Multiple Myeloma : Official Title: A Phase 2 Study of PHE885, B-cell … WebDec 22, 2024 · The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR.

WebCPHE885B12201: National Competent Authority: Italy - Italian Medicines Agency: Clinical Trial Type: EEA CTA: Trial Status: Ongoing: Date on which this record was first entered … WebThe EU Clinical Trials Register currently displays 43368 clinical trials with a EudraCT protocol, of which 7176 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

WebTechnical Summary. A PHASE 2 STUDY OF PHE885, B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED CAR-T CELLS IN ADULT PARTICIPANTS WITH RELAPSED AND …

WebSummary EudraCT Number: 2024-003747-22 Sponsor's Protocol Code Number: CPHE885B12201 National Competent Authority: Italy - Italian Medicines Agency Clinical Trial Type: EEA CTA Tr rum creek facebookWebSponsor Protocol Number: CPHE885B12201: Start Date *: 2024-08-02: Sponsor Name: Novartis Pharma AG Full Title: A Phase 2 study of PHE885, B-cell maturation Antigen … scary horror gameWebCPHE885B12201 NCI-2024-04181 2024-003747-22. Treatment Sites (1) Winship Cancer Institute of Emory University Atlanta Scott Edelman 404-778-5180. 31. Platform Study of … rum cow menu wilmington ncWebThe EU Clinical Trials Register currently displays 43368 clinical trials with a EudraCT protocol, of which 7176 are clinical trials conducted with subjects less than 18 years old. … rumcow in wilmington ncWebcphe885b12201 Therapeutische Studie(I-III) Title: A Phase 2 Study of PHE885, B-cell Maturation Antigen (BCMA)- Directed CAR-T Cells in Adult Participants With Relapsed … rum creek fire community meetingWebTP-PI.MI-WW-008-17 Novartis: Protocol CPHE885B12201 Effective Date: 12 Apr 2024 268539 Image Acquisition Guideline Related to: SOP-PI.MI-WW-001 Version: [v1.0] 2 … scary horror full moviesWebNov 13, 2024 · CPHE885B12201; Scientific Title. Phase II, Open Label, Study of PHE885, a B-cell Maturation Antigen (BCMA)-Directed CAR-T Cells in Adult Patients With Relapsed and Refractory Multiple Myeloma Commercial … scary horror films 2022